Gemtuzumab Ozogamicin

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1018 publications

Analysis of Clinical Impact of CD33 rs12459419 Single-Nucleotide Polymorphism in AML Treated with Intensive Chemotherapy Without Gemtuzumab Ozogamicin.

Analysis of Clinical Impact of CD33 rs12459419 Single-Nucleotide Polymorphism in AML Treated with Intensive Chemotherapy Without Gemtuzumab Ozogamicin.

Journal: International journal of molecular sciences

Published: April 05, 2026

Incidence of Clinically Significant Neutropenia and Complications Related to Antibody-Drug Conjugates: A Real-World Study at the University of California.

Incidence of Clinically Significant Neutropenia and Complications Related to Antibody-Drug Conjugates: A Real-World Study at the University of California.

Journal: Cancers

Published: April 01, 2026

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

Journal: Trials

Published: February 13, 2026

From monoclonals to bispecific T cell engagers: the evolving antibody-based therapy landscape in acute myeloid leukemia.

From monoclonals to bispecific T cell engagers: the evolving antibody-based therapy landscape in acute myeloid leukemia.

Journal: Frontiers in immunology

Published: February 03, 2026

Concomitant Clonal CBFB::MYH11 and PDGFRB Fusions in a Case of De Novo Acute Myeloid Leukemia.

Concomitant Clonal CBFB::MYH11 and PDGFRB Fusions in a Case of De Novo Acute Myeloid Leukemia.

Journal: Hematology reports

Published: January 22, 2026

Frontiers in Antibody-Drug Conjugates: Mechanisms, Design Innovations, and Clinical Applications in Targeted Cancer Therapy.

Frontiers in Antibody-Drug Conjugates: Mechanisms, Design Innovations, and Clinical Applications in Targeted Cancer Therapy.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: January 17, 2026

New horizons for hope of cure in acute myeloid leukemia through immunotherapy: a narrative review.

New horizons for hope of cure in acute myeloid leukemia through immunotherapy: a narrative review.

Journal: Expert review of anticancer therapy

Published: January 08, 2026

Cancer Throughlines: 25 Years after First Approval, ADCs Continue to Pick up Steam.

Cancer Throughlines: 25 Years after First Approval, ADCs Continue to Pick up Steam.

Journal: Cancer discovery

Published: January 05, 2026

The diagnostic potential of nanobodies in acute myeloid leukemia.

The diagnostic potential of nanobodies in acute myeloid leukemia.

Journal: Molecular biology reports

Published: December 22, 2025

Targeting BCL-2 and PI3K signaling pathways enhances cytotoxicity of gemtuzumab ozogamicin against acute myeloid leukemia cells.

Targeting BCL-2 and PI3K signaling pathways enhances cytotoxicity of gemtuzumab ozogamicin against acute myeloid leukemia cells.

Journal: Biochemical and biophysical research communications

Published: December 18, 2025

Integrated analysis of genomics, molecular responses and outcomes of CBF-AML with FLAG based therapy on a phase 2 trial.

Integrated analysis of genomics, molecular responses and outcomes of CBF-AML with FLAG based therapy on a phase 2 trial.

Journal: Blood cancer discovery

Published: December 12, 2025

The anti-CD33 antibody drug conjugate gemtuzumab ozogamicin depletes and functionally resets CD33+ myeloid-derived suppressor cells in patients with metastatic cancer: a phase II single arm, open label trial.

The anti-CD33 antibody drug conjugate gemtuzumab ozogamicin depletes and functionally resets CD33+ myeloid-derived suppressor cells in patients with metastatic cancer: a phase II single arm, open label trial.

Journal: Journal of leukocyte biology

Published: December 12, 2025

Showing 1-12 of 1,018

Last Updated: 06/30/2026